Purespring Therapeutics presents preclinical data at the 61st ERA Congress Purespring Therapeutics presents preclinical data at the 61st ERA Congress Data establishes the potential of AAV gene therapy to deliver transgenes to the podocyte to replace defective genes or to...

Purespring appoints Fredrik Erlandsson as Chief Medical Officer and Peter Mulcahy as Chief People Officer Purespring appoints Fredrik Erlandsson as Chief Medical Officer and Peter Mulcahy as Chief People Officer Appointments of Fredrik and Peter complete build-out of senior team London— 6 September...

Purespring Therapeutics appoints Sachin Kelkar as Chief Financial Officer following appointment of Julian Hanak as Chief Executive Officer Senior leadership team strengthened as Purespring prepares kidney gene therapy programmes for clinical development London— 2 August 2023— Purespring Therapeutics, the pioneering gene therapy...